Difficult biotech investment ecosystem forces focus on value

In 2023, investors pursued pharmaceutical assets with value amidst an unstable economic environment.

Dec 28, 2023 - 18:00

Difficult biotech investment ecosystem forces focus on value

In 2023, investors pursued pharmaceutical assets with value amidst an unstable economic environment.

Read the original article

Tags:

Previous Article

Bristol Myers Squibb agrees to acquire RPT company RayzeBio for $4.1bn

Molecules exhibit non-reciprocal interactions without external forces, new study...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Opinion: Why I left the editorial board of the prestigious scientific journal NeuroImage — and helped start something new

Opinion: Why I left the editorial board of the prestigi...

Feb 1, 2024

Incyte gets grant for treatment of various cancers usin...

Apr 5, 2024

STAT+: Life science investors close nearly $6 billion in new funds

STAT+: Life science investors close nearly $6 billion i...

Nov 1, 2023